MediFast Faces Possible NYSE Delisting

Posted on by Chief Marketer Staff

The New York Stock Exchange has notified Medifast Inc., a direct marketer of diet plans, that it is not in compliance with the its continued listing standards.

Specifically, the company said its total market capitalization over 30 consecutive days fell short of the required $75 million and its most recently reported shareholders’ equity was also below $75 million.

Consequently, MediFast has 45 days to submit a plan to the NYSE to demonstrate its ability to achieve compliance with the continued listing standards within 18 months.

Medifast said it would submit such a plan in time.

More

Related Posts

Chief Marketer Videos

by Chief Marketer Staff

In our latest Marketers on Fire LinkedIn Live, Anywhere Real Estate CMO Esther-Mireya Tejeda discusses consumer targeting strategies, the evolution of the CMO role and advice for aspiring C-suite marketers.

View More 






CALL FOR ENTRIES OPEN





















CALL FOR ENTRIES OPEN




















                

                    

        

	
SIGN UP FOR UPDATES!
 Fill out the fields below to receive the latest news and special announcements from Chief Marketer.